Deep Apple Therapeutics Revenue and Competitors

Location

$57M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Deep Apple Therapeutics's estimated annual revenue is currently $5.3M per year.(i)
  • Deep Apple Therapeutics's estimated revenue per employee is $155,000
  • Deep Apple Therapeutics's total funding is $57M.

Employee Data

  • Deep Apple Therapeutics has 34 Employees.(i)
  • Deep Apple Therapeutics grew their employee count by 17% last year.

Deep Apple Therapeutics's People

NameTitleEmail/Phone
1
VP and Head Drug DiscoveryReveal Email/Phone
2
VP, Head Biology and Translational ResearchReveal Email/Phone
3
VP, Head Biology and Translational ResearchReveal Email/Phone
4
VP and Head Drug DiscoveryReveal Email/Phone
5
Senior Director, Medicinal Chemistry and ADME SciencesReveal Email/Phone
6
Director biologyReveal Email/Phone
7
ScientistReveal Email/Phone
8
Senior Principal Scientist, Head Structural BiologyReveal Email/Phone
9
Senior Scientist - Structural BiologyReveal Email/Phone
10
Principal ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Deep Apple Therapeutics?

In a vast, unexplored virtual chemical space, Deep Apple Therapeutics moves with unprecedented speed to discover novel small molecules for high-value targets. Deep Apple combines ensemble cryo-EM to explore receptor conformations; deep learning; and the docking of multi-billion compound libraries generated using the company's proprietary Orchard.ai™ algorithm. Deep Apple's deep learning discovery engine is built upon founder expertise in computational modeling, protein and target structure determination, large-scale molecular docking, and the elucidation of protein dynamics and conformational transitions. This structure-based, machine-learning driven drug design approach enables the company to rapidly advance novel candidates addressing well-validated targets in inflammatory, metabolic, and endocrine diseases. For more information, visit deepappletx.com.

keywords:N/A

$57M

Total Funding

34

Number of Employees

$5.3M

Revenue (est)

17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6M34-26%N/A
#2
$7.5M34-3%N/A
#3
$3.6M34-62%$26M
#4
$3.9M34N/AN/A
#5
$3.7M340%$44M